Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism

eLife

Volumn 5, Issue JULY, 2016, Pages

  Rando, Gianpaolo ^a   Tan, Chek Kun ^b   Khaled, Nourhène ^a   Montagner, Alexandra ^c   Leuenberger, Nicolas ^a   Bertrand Michel, Justine ^d   Paramalingam, Eeswari ^b   Guillou, Hervé ^c   Wahli, Walter ^a,b,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A ACYLTRANSFERASE; ACYL COENZYME A DEHYDROGENASE; ACYL COENZYME A OXIDASE; ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; ANGIOPOIETIN 4; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CYCLOSERINE; CYTOCHROME P450 4A; DEXAMETHASONE; FATTY ACID BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 21; GLUCOCORTICOID RECEPTOR; GLUCOSE; GROWTH FACTOR; HISTONE DEACETYLASE 3; IMMUNOGLOBULIN G; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; MILK FAT; PEROXIN 19; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PRIMER DNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY LIVER; FETUS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HISTOLOGY; LIPID DIET; LIPOLYSIS; LIVER; LIVER CELL CULTURE; MITOCHONDRION; MOUSE; NEWBORN; NONHUMAN; OXYGEN CONSUMPTION; PEROXISOME; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING; ANIMAL; EMBRYOLOGY; ENERGY METABOLISM; LIPID METABOLISM; METABOLISM; MILK;

ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIPID METABOLISM; LIVER; METABOLISM; MICE; MILK; PPAR ALPHA; RECEPTORS, GLUCOCORTICOID;

EID: 84982706126     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.11853     Document Type: Article

References (65)

1. Aguer C, Gambarotta D, Mailloux RJ, Moffat C, Dent R, McPherson R, Harper ME. 2011. Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells. PLoS One 6: e28536. doi: 10.1371/journal.pone.0028536
2. Anderson SP, Yoon L, Richard EB, Dunn CS, Cattley RC, Corton JC. 2002. Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology 36: 544-554. doi: 10.1053/jhep.2002.35276
3. Archer A, Venteclef N, Mode A, Pedrelli M, Gabbi C, Clément K, Parini P, Gustafsson JA, Korach-AndréM. 2012. Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice. Molecular Endocrinology 26: 1980-1990. doi: 10.1210/me.2012-1151
4. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. 2007. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 5: 426-437. doi: 10.1016/j.cmet.2007.05.002
5. Barlow SM, Morrison PJ, Sullivan FM. 1974. Plasma corticosterone levels during pregnancy in the mouse: the relative contributions of the adrenal glands and foeto-placental units. Journal of Endocrinology 60: 473-483. doi: 10.1677/joe.0.0600473
6. Bougarne N, Paumelle R, Caron S, Hennuyer N, Mansouri R, Gervois P, Staels B, Haegeman G, De Bosscher K. 2009. PPARa blocks glucocorticoid receptor a-mediated transactivation but cooperates with the activated glucocorticoid receptor a for transrepression on NF-kB. PNAS 106: 7397-7402. doi: 10.1073/pnas.0806742106
7. Brawand D, Wahli W, Kaessmann H. 2008. Loss of egg yolk genes in mammals and the origin of lactation and placentation. PLoS Biology 6: e63. doi: 10.1371/journal.pbio.0060063
8. Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RR, Xu HE, Turk J, Semenkovich CF. 2009. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 138: 476-488. doi: 10.1016/j.cell.2009.05.036
9. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF. 2005. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metabolism 1: 309-322. doi: 10.1016/j.cmet.2005.04.002
10. Cherkaoui-Malki M, Surapureddi S, El-Hajj HI, Vamecq J, Andreoletti P. 2012. Hepatic steatosis and peroxisomal fatty acid beta-oxidation. Current Drug Metabolism 13: 1412-1421. doi: 10.2174/138920012803762765
11. Chichlowski M, German JB, Lebrilla CB, Mills DA. 2011. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annual Review of Food Science and Technology 2: 331-351. doi: 10.1146/annurev-food-022510-133743
12. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes & Development 9: 1608-1621. doi: 10.1101/gad.9.13.1608
13. Cotter DG, Ercal B, d’Avignon DA, Dietzen DJ, Crawford PA. 2013. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth. Journal of Biological Chemistry 288: 19739-19749. doi: 10.1074/jbc.M113.454868
14. Cotter DG, Ercal B, d’Avignon DA, Dietzen DJ, Crawford PA. 2014. Impairments of hepatic gluconeogenesis and ketogenesis in PPARa-deficient neonatal mice. American Journal of Physiology. Endocrinology and Metabolism 307: E176-185. doi: 10.1152/ajpendo.00087.2014
15. Cottrell EC, Seckl JR,. 2009. Prenatal stress, glucocorticoids and the programming of adult disease. Frontiers in Behavioral Neuroscience 3: 19. doi: 10.3389/neuro.08.019.2009
16. Desvergne B, Michalik L, Wahli W. 2006. Transcriptional regulation of metabolism. Physiological Reviews 86: 465-514. doi: 10.1152/physrev.00025.2005
17. Dijk W, Kersten S. 2014. Regulation of lipoprotein lipase by Angptl4. Trends in Endocrinology & Metabolism 25: 146-155. doi: 10.1016/j.tem.2013.12.005
18. Edmond J. 1992. Energy metabolism in developing brain cells. Canadian Journal of Physiology and Pharmacology 70 Suppl: S118-S129. doi: 10.1139/y92-253
19. Estall JL, Ruas JL, Choi CS, Laznik D, Badman M, Maratos-Flier E, Shulman GI, Spiegelman BM. 2009. PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis. PNAS 106: 22510-22515. doi: 10.1073/pnas.0912533106
20. Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, Liu XS, Lazar MA. 2011. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331: 1315-1319. doi: 10.1126/science.1198125
21. FerréP, Pégorier JP, Williamson DH, Girard J. 1979. Interactions in vivo between oxidation of non-esterified fatty acids and gluconeogenesis in the newborn rat. Biochemical Journal 182: 593-598. doi: 10.1042/bj1820593
22. Girard J, FerréP, Kervran A, Pegorier JP, Assan R. 1977. Role of the insulin/glucagon ratio in the changes of hepatic metabolism during development of the rat. In: Foa P. P, Bajaj J. S, Foa N. L, Bivens L (Eds). Glucagon: Its Role in Physiology and Clinical Medicine. New York: Springer. p 563-581. doi: 10.1007/978-1-4612-6366-1_36
23. Girard J, FerréP, Pégorier JP, Duée PH. 1992. Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiological Reviews 72: 507-562.
24. Girard J. 1986. Gluconeogenesis in Late Fetal and Early Neonatal Life. Neonatology 50: 237-258. doi: 10.1159/000242605
25. Görs S, Kucia M, Langhammer M, Junghans P, Metges CC. 2009. Technical note: Milk composition in mice-methodological aspects and effects of mouse strain and lactation day. Journal of Dairy Science 92: 632-637. doi: 10.3168/jds.2008-1563
26. Hamosh M. 2004. Human Milk Composition and Function in the Infant. In: Polin R, Fox W, Abman S (Eds). Fetal and Neonatal Physiology. Elsevier Inc. p 275-284. doi: 10.1016/b978-0-7216-9654-6.50032-1
27. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, Yeldandi AV, Rao MS, Reddy JK. 1999. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. Journal of Biological Chemistry 274: 19228-19236. doi: 10.1074/jbc.274.27.19228
28. Hondares E, Rosell M, Gonzalez FJ, Giralt M, Iglesias R, Villarroya F. 2010. Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. Cell Metabolism 11: 206-212. doi: 10.1016/j.cmet.2010.02.001
29. Huyghe S, Casteels M, Janssen A, Meulders L, Mannaerts GP, Declercq PE, Van Veldhoven PP, Baes M. 2001. Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse. Biochemical Journal 353: 673-680. doi: 10.1042/bj3530673
30. Ibarra-Lara L, Del Valle-Mondragón L, Soria-Castro E, Torres-Narváez JC, Pérez-Severiano F, Sánchez-Aguilar M, Ramírez-Ortega M, Cervantes-Pérez LG, Pastelín-Hernández GS, Oidor-Chan VH, Zarco-Olvera G, Sánchez-Mendoza A, Ramírez-Ortega M, Sánchez-Mendoza A. 2016. Peroxisome proliferator-activated receptor-a stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle. Pharmacological Reports 68: 692-702. doi: 10.1016/j.pharep.2016.03.002
31. Ibdah JA, Paul H, Zhao Y, Binford S, Salleng K, Cline M, Matern D, Bennett MJ, Rinaldo P, Strauss AW. 2001. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. Journal of Clinical Investigation 107: 1403-1409. doi: 10.1172/JCI12590
32. Jenness R. 1979. The composition of human milk. Seminars in Perinatology 3: 225-239.
33. Josekutty J, Iqbal J, Iwawaki T, Kohno K, Hussain MM. 2013. Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1a/cJun to enhance plasma ALT/ AST. Journal of Biological Chemistry 288: 14372-14383. doi: 10.1074/jbc.M113.459602
34. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. Journal of Clinical Investigation 103: 1489-1498. doi: 10.1172/JCI6223
35. Koliwad SK, Gray NE, Wang JC. 2012. Angiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting. Adipocyte 1: 182-187. doi: 10.4161/adip.20787
36. Krahling JB, Gee R, Gauger JA, Tolbert NE. 1979. Postnatal development of peroxisomal and mitochondrial enzymes in rat liver. Journal of Cellular Physiology 101: 375-390. doi: 10.1002/jcp.1041010305
37. Lebiedzinska M, Karkucinska-Wieckowska A, Giorgi C, Karczmarewicz E, Pronicka E, Pinton P, Duszynski J, Pronicki M, Wieckowski MR. 2010. Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders. Biochimica Et Biophysica Acta 1797: 952-960. doi: 10.1016/j.bbabio.2010.03.005
38. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W. 1994. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. Journal of Biological Chemistry 269: 24527-24530.
39. Leuenberger N, Pradervand S, Wahli W. 2009. Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. Journal of Clinical Investigation 119: 3138-3148. doi: 10.1172/JCI39019
40. Montagner A, Polizzi A, FouchéE, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, et al. 2016. Liver PPARa is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65: 1202-1214. doi: 10.1136/gutjnl-2015-310798
41. Montagner A, Rando G, Degueurce G, Leuenberger N, Michalik L, Wahli W. 2011. New insights into the role of PPARs. Prostaglandins, Leukotrienes and Essential Fatty Acids 85: 235-243. doi: 10.1016/j.plefa.2011.04.016
42. Nasrin N, Wu X, Fortier E, Feng Y, Bare’ OC, Chen S, Ren X, Wu Z, Streeper RS, Bordone L. 2010. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. Journal of Biological Chemistry 285: 31995-32002. doi: 10.1074/jbc.M110.124164
43. Ockner RK, Kaikaus RM, Bass NM. 1993. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis. Hepatology 18: 669-676. doi: 10.1002/hep.1840180327
44. Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, Ruan HB, Yang X, Caprio S, Kaech SM, Sul HS, Birnbaum MJ, Davis RJ, Cline GW, Petersen KF, Shulman GI. 2015. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 160: 745-758. doi: 10.1016/j.cell.2015.01.012
45. Rakhshandehroo M, Knoch B, Müller M, Kersten S. 2010. Peroxisome proliferator-activated receptor alpha target genes. PPAR Research 2010. doi: 10.1155/2010/612089
46. Reddy JK, Mannaerts GP. 1994. Peroxisomal lipid metabolism. Annual Review of Nutrition 14: 343-370. doi: 10.1146/annurev.nu.14.070194.002015
47. Rodríguez JC, Gil-Gómez G, Hegardt FG, Haro D. 1994. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids. Journal of Biological Chemistry 269: 18767-18772.
48. Salgado MC, Metón I, Anemaet IG, Baanante IV. 2014. Activating transcription factor 4 mediates up-regulation of alanine aminotransferase 2 gene expression under metabolic stress. Biochimica Et Biophysica Acta 1839: 288-296. doi: 10.1016/j.bbagrm.2014.01.005
49. Serra D, Bellido D, Asins G, Arias G, VilaróS, Hegardt FG. 1996. The expression of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme-A synthase in neonatal rat intestine and liver is under transcriptional control. European Journal of Biochemistry 237: 16-24. doi: 10.1111/j.1432-1033.1996.0016n.x
50. Serra D, Casals N, Asins G, Royo T, Ciudad CJ, Hegardt FG. 1993. Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. Archives of Biochemistry and Biophysics 307: 40-45. doi: 10.1006/abbi.1993.1557
51. Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV, de Cabo R, Ulrich S, Akassoglou K, Verdin E. 2013. Suppression of oxidative stress by b-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339: 211-214. doi: 10.1126/science.1227166
52. Smith S, Watts R, Dils R. 1968. Quantitative gas-liquid chromatographic analysis of rodent milk triglycerides. Journal of Lipid Research 9: 52-57.
53. Speirs HJ, Seckl JR, Brown RW. 2004. Ontogeny of glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development. Journal of Endocrinology 181: 105-116. doi: 10.1677/joe.0.1810105
54. Strober W. 2001. Trypan blue exclusion test of cell viability. Current Protocols in Immunology Appendix 3: Appendix 3B. doi: 10.1002/0471142735.ima03bs21
55. Su Q, Baker C, Christian P, Naples M, Tong X, Zhang K, Santha M, Adeli K. 2014. Hepatic mitochondrial and ER stress induced by defective PPARa signaling in the pathogenesis of hepatic steatosis. Endocrinology and Metabolism 306: E1264-E1273. doi: 10.1152/ajpendo.00438.2013
56. Suski JM, Lebiedzinska M, Bonora M, Pinton P, Duszynski J, Wieckowski MR. 2012. Relation between mitochondrial membrane potential and ROS formation. Methods in Molecular Biology 810: 183-205. doi: 10.1007/978-1-61779-382-0_12
57. Tanimizu N, Nishikawa M, Saito H, Tsujimura T, Miyajima A. 2003. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. Journal of Cell Science 116: 1775-1786. doi: 10.1242/jcs.00388
58. Tirosh O, Ilan E, Anavi S, Ramadori G, Madar Z. 2009. Nutritional lipid-induced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes. Nutrition 25: 200-208. doi: 10.1016/j.nut.2008.07.023
59. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. 1992. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. The EMBO Journal 11: 433-439.
60. Vilà-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF. 2011. Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. Journal of Biological Chemistry 286: 20423-20430. doi: 10.1074/jbc.M111.235044
61. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. 2009. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138: 1019-1031. doi: 10.1016/j.cell.2009.06.049
62. Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R, Li YS, Lindberg RA, Chen JL, Jung DY, Zhang Z, Ko HJ, Kim JK, Véniant MM, Young Jung D. 2009. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58: 250-259. doi: 10.2337/db08-0392
63. Xu J, Xiao G, Trujillo C, Chang V, Blanco L, Joseph SB, Bassilian S, Saad MF, Tontonoz P, Lee WN, Kurland IJ. 2002. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. Journal of Biological Chemistry 277: 50237-50244. doi: 10.1074/jbc.M201208200
64. Yubero P, Hondares E, Carmona MC, Rossell M, Gonzalez FJ, Iglesias R, Giralt M, Villarroya F. 2004. The developmental regulation of peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression in the liver is partially dissociated from the control of gluconeogenesis and lipid catabolism. Endocrinology 145: 4268-4277. doi: 10.1210/en.2004-0099
65. Zadravec D, Brolinson A, Fisher RM, Carneheim C, Csikasz RI, Bertrand-Michel J, Borén J, Guillou H, Rudling M, Jacobsson A. 2010. Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. FASEB Journal 24: 4366-4377. doi: 10.1096/fj.09-152298